Doxazosin Extended-Release Tablets and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Doxazosin Extended-Release Tablets and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: doxazosin
Brand name: Cardura, Cardura XL, Doxadura, Cascor, Carduran
Synonyms: Doxazosin
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Doxazosin Extended-Release Tablets-Insulin degludec
- Doxazosin Extended-Release Tablets-Insulin Degludec (U-100) Prefilled Pens
- Doxazosin Extended-Release Tablets-Insulin Degludec (U-100) Vials
- Doxazosin Extended-Release Tablets-Insulin Degludec (U-200) Prefilled Pens
- Doxazosin Extended-Release Tablets-Insulin degludec and liraglutide
- Doxazosin Extended-Release Tablets-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Doxazosin Mesylate
- Insulin aspart, recombinant Subcutaneous-Doxazosin Tablets
- Insulin aspart, recombinant Subcutaneous-Doxepin
- Insulin aspart, recombinant Subcutaneous-Doxepin (Systemic)
- Insulin aspart, recombinant Subcutaneous-Doxepin Capsules
- Insulin aspart, recombinant Subcutaneous-Doxepin Cream